Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Trial to Evaluate the Efficacy of Low-dose Intracoronary Tenecteplase in ST-Elevation Myocardial Infarction (STEMI) Patients With High Microvascular Resistance Post-percutaneous Coronary Intervention (PCI).

NCT03998319 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT03998319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03998319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Trial to Evaluate the Efficacy of Low-dose Intracoronary Tenecteplase in ST-Elevation Myocardial Infarction (STEMI) Patients With High Microvascular Resistance Post-percutaneous Coronary Intervention (PCI).
Lead sponsor
University of Sydney
Phase
Phase 3
Overall status
Recruiting
Start date
October 14, 2021
Completion date
December 31, 2026
Enrollment
445 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

elevated imr (>32), stemi